Micro-Flow Imaging Brochure

Do you need to answer tough questions about sub-visible particles? Regulatory agencies are concerned about undesired side effects and reduced efficacy and require them to be well-characterized in biopharmaceutical formulations. But as their name implies, doing that can sometimes be a challenge. The MFI 5000 Series detects, quantitates and differentiates particles that you may not see now. Read the brochure to find out more.